Notification of Results

Futura Medical PLC 04 March 2008 For immediate release 4 March 2008 Futura Medical plc Notification of Preliminary Results Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, informs the London Stock Exchange that their preliminary results for the year ended 31 December 2007 will be announced on Thursday 13 March 2008. For further information: Futura Medical plc James Barder, Chief Executive Tel: +44 (0) 1483 685 670 mail to: james.barder@futuramedical.co.uk www.futuramedical.co.uk Media enquiries: Buchanan Communications Mark Court / Rebecca Skye Dietrich Tel: +44 (0) 20 7466 5000 Nominated Adviser: Canaccord Adams Limited Mark Williams / Erin Needra Tel: +44 (0) 20 7050 6500 Notes Futura Medical plc Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups. Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.co.uk This information is provided by RNS The company news service from the London Stock Exchange
UK 100